Companies included in BIB Page 3
This is BIB's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 201–278 of 278.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| MGTX | MeiraGTx Holdings plc | 3,717 | NS | 0.030641% |
| REPL | Replimune Group, Inc. | 3,622 | NS | 0.030213% |
| DSGN | Design Therapeutics, Inc. | 2,630 | NS | 0.029939% |
| NMRA | Neumora Therapeutics, Inc. | 7,715 | NS | 0.029359% |
| CRMD | CorMedix, Inc. | 3,638 | NS | 0.028284% |
| IRWD | Ironwood Pharmaceuticals, Inc. | 7,512 | NS | 0.028013% |
| FDMT | 4D Molecular Therapeutics, Inc. | 2,638 | NS | 0.027787% |
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | 4,990 | NS | 0.02726% |
| VNDA | Vanda Pharmaceuticals, Inc. | 2,729 | NS | 0.026513% |
| LXEO | Lexeo Therapeutics, Inc. | 3,370 | NS | 0.026384% |
| MRVI | Maravai LifeSciences Holdings, Inc. | 6,696 | NS | 0.025992% |
| LYEL | Lyell Immunopharma, Inc. | 979 | NS | 0.02562% |
| PACB | Pacific Biosciences of California, Inc. | 13,941 | NS | 0.025538% |
| ZVRA | Zevra Therapeutics, Inc. | 2,600 | NS | 0.025317% |
| KMDA | Kamada Ltd. | 2,664 | NS | 0.025272% |
| AQST | Aquestive Therapeutics, Inc. | 5,633 | NS | 0.024569% |
| Galapagos NV | Galapagos NV | 668 | NS | 0.024517% |
| SLDB | Solid Biosciences, Inc. | 3,598 | NS | 0.024363% |
| IVVD | Invivyd, Inc. | 12,796 | NS | 0.02358% |
| Prothena Corp. plc | Prothena Corp. plc | 2,485 | NS | 0.023492% |
| SIGA | SIGA Technologies, Inc. | 3,307 | NS | 0.02333% |
| RGNX | REGENXBIO, Inc. | 2,337 | NS | 0.023036% |
| TRDA | Entrada Therapeutics, Inc. | 1,765 | NS | 0.02296% |
| ETON | Eton Pharmaceuticals, Inc. | 1,239 | NS | 0.022953% |
| LRMR | Larimar Therapeutics, Inc. | 3,953 | NS | 0.022888% |
| FULC | Fulcrum Therapeutics, Inc. | 2,499 | NS | 0.022835% |
| ALT | Altimmune, Inc. | 4,819 | NS | 0.022647% |
| TECX | Tectonic Therapeutic, Inc. | 864 | NS | 0.022092% |
| KROS | Keros Therapeutics, Inc. | 1,406 | NS | 0.021755% |
| PEPG | PepGen, Inc. | 3,175 | NS | 0.021534% |
| LENZ | LENZ Therapeutics, Inc. | 1,445 | NS | 0.021255% |
| UPB | Upstream Bio, Inc. | 2,495 | NS | 0.020894% |
| ENTA | Enanta Pharmaceuticals, Inc. | 1,332 | NS | 0.020769% |
| ABSI | Absci Corp. | 6,944 | NS | 0.020746% |
| AVXL | Anavex Life Sciences Corp. | 4,125 | NS | 0.019926% |
| AURA | Aura Biosciences, Inc. | 2,932 | NS | 0.01883% |
| AVIR | Atea Pharmaceuticals, Inc. | 3,607 | NS | 0.018407% |
| NGNE | Neurogene, Inc. | 715 | NS | 0.018314% |
| KYTX | Kyverna Therapeutics, Inc. | 2,023 | NS | 0.01811% |
| CTNM | Contineum Therapeutics, Inc. | 1,067 | NS | 0.017847% |
| AUTL | Autolus Therapeutics plc | 9,262 | NS | 0.01727% |
| NBP | NovaBridge Biosciences | 4,801 | NS | 0.017171% |
| IMRX | Immuneering Corp. | 2,981 | NS | 0.01622% |
| FHTX | Foghorn Therapeutics, Inc. | 2,611 | NS | 0.016171% |
| CABA | Cabaletta Bio, Inc. | 4,445 | NS | 0.016091% |
| ACRS | Aclaris Therapeutics, Inc. | 5,003 | NS | 0.015657% |
| ACIU | AC Immune SA | 4,636 | NS | 0.014811% |
| CADL | Candel Therapeutics, Inc. | 2,535 | NS | 0.014512% |
| PBYI | Puma Biotechnology, Inc. | 2,326 | NS | 0.014457% |
| EOLS | Evolus, Inc. | 2,993 | NS | 0.014033% |
| AARD | Aardvark Therapeutics, Inc. | 1,005 | NS | 0.013687% |
| LFCR | Lifecore Biomedical, Inc. | 1,730 | NS | 0.013582% |
| BCYC | Bicycle Therapeutics plc | 2,136 | NS | 0.013346% |
| CCCC | C4 Therapeutics, Inc. | 4,475 | NS | 0.013175% |
| VOR | Vor BioPharma, Inc. | 778 | NS | 0.013098% |
| Silence Therapeutics plc | Silence Therapeutics plc | 2,169 | NS | 0.012866% |
| OmniAb, Inc. | OmniAb, Inc. | 6,647 | NS | 0.012466% |
| OBIO | Orchestra BioMed Holdings, Inc. | 2,607 | NS | 0.012451% |
| VYGR | Voyager Therapeutics, Inc. | 2,721 | NS | 0.012165% |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 1,312 | NS | 0.011774% |
| EDIT | Editas Medicine, Inc. | 4,508 | NS | 0.010814% |
| Humacyte, Inc. | Humacyte, Inc. | 8,647 | NS | 0.010513% |
| CHRS | Coherus Oncology, Inc. | 5,581 | NS | 0.010163% |
| Quantum-Si, Inc. | Quantum-Si, Inc. | 9,030 | NS | 0.009417% |
| CRBU | Caribou Biosciences, Inc. | 4,316 | NS | 0.008942% |
| SGMT | Sagimet Biosciences, Inc. | 1,432 | NS | 0.008916% |
| MENS | Jyong Biotech Ltd. | 3,511 | NS | 0.008193% |
| BDTX | Black Diamond Therapeutics, Inc. | 2,631 | NS | 0.007086% |
| TKNO | Alpha Teknova, Inc. | 2,471 | NS | 0.006951% |
| RANI | Rani Therapeutics Holdings, Inc. | 4,504 | NS | 0.006728% |
| GOSS | Gossamer Bio, Inc. | 10,687 | NS | 0.004951% |
| TNYA | Tenaya Therapeutics, Inc. | 7,688 | NS | 0.00471% |
| PYXS | Pyxis Oncology, Inc. | 2,875 | NS | 0.004608% |
| CDXS | Codexis, Inc. | 4,171 | NS | 0.004594% |
| STRO | Sutro Biopharma, Inc. | 1 | NS | 0.000022% |
| Third Harmonic Bio, Inc. | Third Harmonic Bio, Inc. | 1,662 | NS | 0% |
| RNAC | Cartesian Therapeutics, Inc. | 9,785 | NS | 0% |
| N/A | N/A | 633 | NC | -1.813126% |
SEC N-PORT snapshot as of .